Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ApoL1 and the Immune Response of Patients with Systemic Lupus Erythematosus.

Current rheumatology reports - 1 Mar 2017

Blazer Ashira D, Clancy Robert M

Abstract excerpt

PURPOSE OF REVIEW: Systemic lupus erythematosus (SLE) confers up to a 50-fold increased risk of cardiovascular disease (CVD), and African Americans with SLE experience accelerated damage accrual and doubled cardiovascular risk when compared to their European American counterparts. RECENT FINDINGS: Genome-wide association studies have identified a substantial signal at 22q13, now assigned to variation at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein L1
Share to Apolipoproteins
Share to Autophagy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiovascular Diseases

Share to Genome-Wide Association Study

Share to Lipoproteins, HDL

Share to Lupus Erythematosus, Systemic

Share to Lupus Nephritis

Source

Identifiers

PMID: 28265848
DOI: 10.1007/s11926-017-0637-9

Genes

APOL1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ApoL1 and the Immune Response of Patients with Systemic Lupus Erythematosus.PMID 28265848Read ↗

From Genes to Pathways: The Molecular Landscape of Systemic Lupus Erythematosus.Semantic proximity Read ↗

APOL1 toxin, innate immunity, and kidney injury.Semantic proximity Read ↗

Concepts in lupus pathophysiology: Lessons learned from disease across the spectrum.Semantic proximity Read ↗

New insights into the immunopathogenesis of systemic lupus erythematosus.Semantic proximity Read ↗

Gene of the month: APOL1.Semantic proximity Read ↗

A Cell Biologist’s View on APOL1: What We Know and What We Still Need to AddressSemantic proximity Read ↗

The role of autophagy in the pathogenesis of systemic lupus erythematosus.Semantic proximity Read ↗

Autophagy and immunological aberrations in systemic lupus erythematosusSemantic proximity Read ↗

Systemic lupus erythematosus-accelerated atherosclerosis: mechanistic insights and clinical implications.Semantic proximity Read ↗

Collapsing glomerulopathy in a patient with APOL1 intermediate-risk genotype triggered by lupus nephritis and SARS-CoV-2 infection: lessons for the clinical nephrologist.Semantic proximity Read ↗

Apolipoprotein L1 and mechanisms of kidney disease susceptibility.Semantic proximity Read ↗

The lupus susceptibility allele <i>DRB1*03:01</i> encodes a disease-driving epitopeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.